GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alto Neuroscience Inc (NYSE:ANRO) » Definitions » 6-1 Month Momentum %

ANRO (Alto Neuroscience) 6-1 Month Momentum % : -62.31% (As of Dec. 15, 2024)


View and export this data going back to 2024. Start your Free Trial

What is Alto Neuroscience 6-1 Month Momentum %?

6-1 Month Momentum % is the total return of the stock from 6-month ago to 1-month ago. As of today (2024-12-15), Alto Neuroscience's 6-1 Month Momentum % is -62.31%.

The industry rank for Alto Neuroscience's 6-1 Month Momentum % or its related term are showing as below:

ANRO's 6-1 Month Momentum % is ranked worse than
91.92% of 1473 companies
in the Biotechnology industry
Industry Median: -9.53 vs ANRO: -62.31

Competitive Comparison of Alto Neuroscience's 6-1 Month Momentum %

For the Biotechnology subindustry, Alto Neuroscience's 6-1 Month Momentum %, along with its competitors' market caps and 6-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alto Neuroscience's 6-1 Month Momentum % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alto Neuroscience's 6-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Alto Neuroscience's 6-1 Month Momentum % falls into.



Alto Neuroscience  (NYSE:ANRO) 6-1 Month Momentum % Calculation

6-1 Month Momentum % is calculated as following:

6-1 Month Momentum %=( Price 1-month ago / Price 6-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Alto Neuroscience  (NYSE:ANRO) 6-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 6-1 Month Momentum % measures the total return to a stock over the past six months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Alto Neuroscience 6-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Alto Neuroscience's 6-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Alto Neuroscience Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
369 South San Antonio Road, Los Altos, CA, USA, 94022
Alto Neuroscience Inc is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individuals' neurobiology to develop personalized and effective treatment options. The company currently consists of different clinical-stage assets such as ALTO-100, ALTO-202, ALTO-101, and ALTO-300 among others initially targeting depressive disorders and schizophrenia populations as identified by independent brain-based biomarkers.

Alto Neuroscience Headlines